The first Monday in May is known as ‘Melanoma Monday'
The American Academy of Dermatology started the day in 1995 to raise awareness about skin cancer.
FOX8's Cindy Farmer speaks with a radiation oncologist to find out about radiation treatment for skin cancer in the FOX8 House Call.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
5 hours ago
- Business Wire
The Beachbody Company, Inc. Announces Transfer of Stock Exchange Listing to Nasdaq
EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NYSE: BODi) (the 'Company') today announced that it will voluntarily transfer the listing of its Class A common stock to the Nasdaq Capital Market from the New York Stock Exchange ('NYSE'). The Company expects to begin trading as a Nasdaq-listed company on September 3, 2025. Following the transfer to Nasdaq, the Company's common stock will continue to trade under the symbol 'BODI'. 'Our move to Nasdaq will allow us to leverage their advanced trading technology and market data services to better serve our shareholders. As we continue to successfully execute against our strategic transformation, we're excited to join a community of the world's most dynamic companies on an exchange that shares our commitment to innovation,' commented Carl Daikeler, BODi's co-founder and Chief Executive Officer. 'Nasdaq has established itself as the premier destination for innovative game-changers that are reshaping their industries, disrupting traditional business models and creating new market opportunities. This move aligns BODi with a marketplace that values and supports transformative companies like ours,' said Mark Goldston, Executive Chairman of BODi. About BODi and The Beachbody Company, Inc. Originally known as Beachbody, BODi has been innovating structured step-by-step home fitness and nutrition programs for 25 years such as P90X, Insanity, and 21-Day Fix, plus the first premium superfood nutrition supplement, Shakeology. Since its inception in 1999 BODi has helped over 30 million customers pursue extraordinary life-changing results. The BODi community represents millions of people helping each other stay accountable to goals of healthy weight loss, improved strength and energy, and resilient mental and physical well-being. For more information, please visit Forward-Looking Statements This press release of The Beachbody Company, Inc. ('we,' 'us,' 'our,' and similar terms) contains 'forward-looking' statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are statements other than statements of historical facts and statements in future tense, including statements regarding the commencement of trading of our Class A common stock on the Nasdaq Capital Market. Forward-looking statements are based upon various estimates and assumptions, as well as information known to us as of the date hereof, and are subject to risks and uncertainties. Accordingly, actual results could differ materially due to a variety of factors, including: our ability to effectively compete in the fitness and nutrition industries; our ability to successfully acquire and integrate new operations; our reliance on a few key products; market conditions and global and economic factors beyond our control; intense competition and competitive pressures from other companies worldwide in the industries in which we operate; litigation and the ability to adequately protect our intellectual property rights; and the successful transfer of the listing of our Class A common stock on the Nasdaq. You can identify these statements by the use of terminology such as 'believe', 'plans', 'expect', 'will', 'should,' 'could', 'estimate', 'anticipate' or similar forward-looking terms. You should not rely on these forward-looking statements as they involve risks and uncertainties that may cause actual results to vary materially from the forward-looking statements. For more information regarding the risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements, as well as risks relating to our business in general, we refer you to the 'Risk Factors' section of our Securities and Exchange Commission filings, including those risks and uncertainties included in the Form 10-K filed with the SEC on March 28, 2025 and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, which are available on the Investor Relations page of our website at and on the SEC website at All forward-looking statements contained herein are based on information available to us as of the date hereof and you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance, or achievements. We undertake no obligation to update any of these forward-looking statements for any reason after the date of this press release or to conform these statements to actual results or revised expectations, except as required by law. Undue reliance should not be placed on forward-looking statements.
Business Wire
5 hours ago
- Business Wire
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. ('Sonendo' or the 'Company') (OTC Pink: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the promotion of John McGaugh to Chief Operating Officer. Mr. McGaugh previously held the position of Senior Vice President of Operations. 'Since Sonendo embarked on its strategic reset in early-2024, the Company has stabilized revenue, generated significant leverage in gross margin, and meaningfully lowered total operating expenses, adjusted EBITDA loss and cash burn,' stated Bjarne Bergheim, President and Chief Executive Officer of Sonendo. 'John has been a significant contributor to all those improvements, and we expect he will continue to drive additional operating leverage as the Company continues to execute its plans to achieve profitability. John is a valuable member of the team, and I am excited to see him take on the role of Chief Operating Officer.' In addition to his previous responsibilities overseeing quality, manufacturing, supply chain, and technical services operations, Mr. McGaugh now has oversight of Sonendo's capital and consumables sales teams and commercial operations. Mr. McGaugh has over 20 years overseeing global manufacturing operations. He joined Sonendo in May 2023 and has been instrumental in leading significant operational efficiencies with console assembly and procedure instrument margin contributions. Prior to his time at Sonendo, Mr. McGaugh served as a multi-site operational leader for Abbott Vascular. In addition to his experience at Abbott, Mr. McGaugh has held leadership roles at Boston Scientific and American Medical Systems. About Sonendo Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. For more information about Sonendo and the GentleWave System, please visit To find a GentleWave doctor in your area, please visit Forward Looking Statements This news release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the Company's ability to continue to drive additional operating leverage and/or execute its plans to achieve profitability, whether as a result of Mr. McGaugh or otherwise. You are cautioned that such statements are not guarantees of future performance and that our actual results may differ materially from those set forth in the forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions; speak only as of the date they are made; and, as a result, are subject to risks and uncertainties that may change at any time. Factors that could cause the Company's actual results to differ materially from these forward-looking statements are described in detail in the 'Risk Factors' section of the Company's Annual Report on Form 10-K that was filed with the Securities and Exchange Commission on March 26, 2025. Such filings are available at The Company undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Yahoo
5 hours ago
- Yahoo
Deadly NYC Legionnaires' disease outbreak fueled by negligence, lawsuit says
Civil rights attorney Ben Crump has filed lawsuits against two construction companies over what he called a "completely preventable" outbreak of Legionnaires' disease that has killed five people and sickened more than 100 others in New York City. Legionnaires' disease is a severe pneumonia caused by a type of bacteria called Legionella, which grows in warm or hot water, according to the Centers for Disease Control and Prevention. An outbreak of the disease, which began on July 25, has been clustered across five zip codes in Central Harlem. The city health department said the outbreak is linked to cooling towers, heat exchangers that use fans and water to cool down buildings. On Aug. 14, health officials confirmed that 12 cooling towers at buildings including NYC Health + Hospitals/Harlem tested positive for the Legionella bacteria. Crump and other attorneys filed complaints on behalf of two construction workers who were hospitalized with Legionnaire's disease in July after working near the hospital in Harlem, according to a news release. Crump said the legal team has also filed a notice of claim and intend to sue the city as well. "It is believed that the cooling towers at Harlem Hospital were filled with rainwater after several large July storms," the release said. "The water was left untreated, which permitted bacteria to spread causing workers at the site to become sick." Construction companies, city accused of negligence Crump accused Skanska USA Building, Inc., Rising Sun Construction LLC and the city of negligence at a news conference on Aug. 20, announcing the lawsuits. The attorneys said the construction companies were put on notice about the possibility of Legionella bacteria through bulletins after the storms, but failed to take action to keep those working near the hospital safe. "When corporations cut corners, tragedies like this happen. Preventable tragedies, unnecessary tragedies," Crump said. Crump said the lawsuit is seeking not only compensation for the workers but also accountability and answers about why this outbreak occurred in Harlem — a historically Black neighborhood in Upper Manhattan. Skanska and Rising Sun did not immediately respond to a request for comment from USA TODAY. Christopher Miller, a spokesperson for NYC Health + Hospitals, said in a statement the agency has "one of the most rigorous cooling tower safety and inspection programs, exceeding City testing and cleaning requirements." "We inspect towers every day; further, we look for legionella weekly instead of the required every 90 days," the statement said. "We continue to work with our cooling tower maintenance firm and the NYC Health Department to best serve our patients and the Harlem community.' When asked about Crump's claims about the source of the outbreak, a spokesperson for the city's health department said the investigation is ongoing. "Molecular testing may help us determine which cooling tower — or cooling towers — were the source of the bacteria in the Central Harlem cluster," spokesperson Chantal Gomez said in a statement. "The Public Health Lab is still determining a match through DNA sequencing and we expect final results soon.' Electrian describes gasping for air while hospitalized with Legionnaire's Nunzio Quinto, a union electrian who worked at a ground-up construction of the NewYork City Public Health Laboratory, a 10-story facility adjacent to the hospital complex, said he thought he had food poisoning when he first started feeling lethargic in late July. Quinto said his family took him to the hospital, where he was immediately diagnosed with Legionnaire's disease. He suffered breathing problems, pain and internal bleeding during a five-day stay in the hospital, but said his coworkers weren't notified of his illness. "I want answers to what's going on. I can't have a safe place to work? This is New York City," Quinto said at the news conference. Contributing: Thao Nguyen This article originally appeared on USA TODAY: Lawsuit blames Legionnaires' disease outbreak on negligence
